At Amertaat, every claim is backed by research.
We collaborate with neuroscientists and nutrition experts to ensure each ingredient in Amertaat Zen meets the highest standards of safety, purity, and efficacy.
At Amertaat, every claim is backed by research.
We collaborate with neuroscientists and nutrition experts to ensure each ingredient in Amertaat Zen meets the highest standards of safety, purity, and efficacy.
In the double-blind, placebo-controlled, crossover study in healthy men (age 18-25) – a single 30 mg dose of Safr’Inside™ vs placebo vs synthetic safranal: Safr’Inside™ significantly delayed cortisol/cortisone peak times and reduced self-reported stress/anxiety.
Crocus sativus L. Versus Methylphenidate in Treatment of Children and Adolescents with ADHD (2018) – A randomized clinical trial that found saffron extract to have satisfactory outcomes compared with methylphenidate in children with ADHD.
Meta-analysis of saffron in mood disorders: A review covering saffron extract in various trials found significant protective effects in depression, some cognitive and metabolic disorders — showing saffron’s promise in neuro-emotional health.
Sleep study: In older adults (55-85) with sleep complaints, 30 mg/day of standardised saffron extract for 4 weeks improved subjective sleep quality (PSQI), improved sleep efficiency, reduced sleep latency, and modulated gut microbiota (e.g., ↑ Faecalibacterium, Lachnoclostridium) which correlated with improved sleep parameters.
Patent validation: The extract’s patent (EP3490575B1/WO2017EP69200) supports the unique extraction and standardisation of the saffron extract, underscoring its premium botanical status.
In the double-blind, placebo-controlled, crossover study in healthy men (age 18-25) – a single 30 mg dose of Safr’Inside™ vs placebo vs synthetic safranal: Safr’Inside™ significantly delayed cortisol/cortisone peak times and reduced self-reported stress/anxiety.
Crocus sativus L. Versus Methylphenidate in Treatment of Children and Adolescents with ADHD (2018) – A randomized clinical trial that found saffron extract to have satisfactory outcomes compared with methylphenidate in children with ADHD.
Meta-analysis of saffron in mood disorders: A review covering saffron extract in various trials found significant protective effects in depression, some cognitive and metabolic disorders - showing saffron’s promise in neuro-emotional health.
Sleep study: In older adults (55-85) with sleep complaints, 30 mg/day of standardised saffron extract for 4 weeks improved subjective sleep quality (PSQI), improved sleep efficiency, reduced sleep latency, and modulated gut microbiota (e.g., ↑ Faecalibacterium, Lachnoclostridium) which correlated with improved sleep parameters.
Patent validation: The extract’s patent (EP3490575B1/WO2017EP69200) supports the unique extraction and standardisation of the saffron extract, underscoring its premium botanical status.
Amertaat is a dietary supplement intended to support wellbeing. It is not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before use, especially for children under 18 or if pregnant, nursing, or taking medication.
Amertaat is a dietary supplement intended to support wellbeing. It is not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before use, especially for children under 18 or if pregnant, nursing, or taking medication.
English English 
Italiano
